Search Results 1461-1470 of 21415 for platelets

1. Neurology - Clinical trials - Mayo Clinic

   ... platelets ≥ 100,000 /microliter, performed within 7 days prior to the collection. Pagination Clinical studies. PrevPrevious Page · Go to page 77 · Go to page 8 ...

2. Medical Research & Education - Mayo Clinic News Network

   Platelet-rich plasma: A regenerative approach to healing chronic wounds. Mayo Clinic Staff. September 30, 2021. Research. An inside look at the state-of-the-art ...

3. Clinical trials - Oncology (Medical)

   ... platelets ≥ 100,000 /microliter, performed within 7 days prior to the collection. Pre-myeloid Cancer and Bone Marrow Failure Clinic Study. Rochester, Minn ...

4. Orthopedic Surgery Physicians - Medical Professionals - Mayo Clinic

   ... Platelet rich plasma injection, Ultrasound-guided percutaneous fasciotomy, Bone marrow aspirate concentrate injection, Viscosupplementation, Nerve block ...

5. A study to test whether survodutide helps people with a liver disease called NASH/MASH who have cirrhosis - Mayo Clinic

   ... Platelets ≤ 110,000/µL (≤ 110 GI/L) NOTE 3: Metabolic comorbidities ... Platelet count < 100,000/µL (< 100 GI/L). History or evidence of other chronic ...

6. Medical Research & Education - Mayo Clinic News Network

   Platelet-rich plasma: A regenerative approach to healing chronic wounds. Mayo Clinic Staff. September 30, 2021. Research. An inside look at the state-of-the-art ...

7. Medical Research & Education - Mayo Clinic News Network

   Platelet-rich plasma: A regenerative approach to healing chronic wounds. Mayo Clinic Staff. September 30, 2021. Research. An inside look at the state-of-the-art ...

8. Physical Medicine and Rehabilitation Physicians - Medical Professionals - Mayo Clinic

   ... Platelet rich plasma injection, Nerve hydrodissection, Percutaneous tenotomy, Tenotomy-fasciotomy with Tenex technology, Sports injury, Hamstring injury ...

9. Nitisinone (oral route) - Side effects & dosage - Mayo Clinic

   It can also lower the number of platelets, which are necessary for proper blood clotting. If this occurs, there are certain precautions you can take ...

10. A Phase 1b/2a Multicenter, Open-Label, Dose-Escalation Study to Determine the Maximum Tolerated Dose, Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CC-220 as Monotherapy and in Combination with Other Treatments in Subjects with Multiple Myeloma - Mayo Clinic

    Platelet count < 75,000/μL for Part 1. For Part 2; platelet count < 75,000/μL for subjects in whom < 50% of bone marrow nucleated cells are plasma cells ...